First Time Loading...

Beigene Ltd
HKEX:6160

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
HKEX:6160
Watchlist
Price: 89.85 HKD 3.28% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

Beigene Ltd is a biotechnology company in the commercial stage. [ Read More ]

The intrinsic value of one Beigene Ltd stock under the Base Case scenario is 126.33 HKD. Compared to the current market price of 89.85 HKD, Beigene Ltd is Undervalued by 29%.

Key Points:
Intrinsic Value
Base Case
126.33 HKD
Undervaluation 29%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Beigene Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Beigene Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Beigene Ltd

Provide an overview of the primary business activities
of Beigene Ltd.

What unique competitive advantages
does Beigene Ltd hold over its rivals?

What risks and challenges
does Beigene Ltd face in the near future?

Summarize the latest earnings call
of Beigene Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Beigene Ltd.

Provide P/S
for Beigene Ltd.

Provide P/E
for Beigene Ltd.

Provide P/OCF
for Beigene Ltd.

Provide P/FCFE
for Beigene Ltd.

Provide P/B
for Beigene Ltd.

Provide EV/S
for Beigene Ltd.

Provide EV/GP
for Beigene Ltd.

Provide EV/EBITDA
for Beigene Ltd.

Provide EV/EBIT
for Beigene Ltd.

Provide EV/OCF
for Beigene Ltd.

Provide EV/FCFF
for Beigene Ltd.

Provide EV/IC
for Beigene Ltd.

Show me price targets
for Beigene Ltd made by professional analysts.

What are the Revenue projections
for Beigene Ltd?

How accurate were the past Revenue estimates
for Beigene Ltd?

What are the Net Income projections
for Beigene Ltd?

How accurate were the past Net Income estimates
for Beigene Ltd?

What are the EPS projections
for Beigene Ltd?

How accurate were the past EPS estimates
for Beigene Ltd?

What are the EBIT projections
for Beigene Ltd?

How accurate were the past EBIT estimates
for Beigene Ltd?

Compare the revenue forecasts
for Beigene Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Beigene Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Beigene Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Beigene Ltd compared to its peers.

Compare the P/E ratios
of Beigene Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Beigene Ltd with its peers.

Analyze the financial leverage
of Beigene Ltd compared to its main competitors.

Show all profitability ratios
for Beigene Ltd.

Provide ROE
for Beigene Ltd.

Provide ROA
for Beigene Ltd.

Provide ROIC
for Beigene Ltd.

Provide ROCE
for Beigene Ltd.

Provide Gross Margin
for Beigene Ltd.

Provide Operating Margin
for Beigene Ltd.

Provide Net Margin
for Beigene Ltd.

Provide FCF Margin
for Beigene Ltd.

Show all solvency ratios
for Beigene Ltd.

Provide D/E Ratio
for Beigene Ltd.

Provide D/A Ratio
for Beigene Ltd.

Provide Interest Coverage Ratio
for Beigene Ltd.

Provide Altman Z-Score Ratio
for Beigene Ltd.

Provide Quick Ratio
for Beigene Ltd.

Provide Current Ratio
for Beigene Ltd.

Provide Cash Ratio
for Beigene Ltd.

What is the historical Revenue growth
over the last 5 years for Beigene Ltd?

What is the historical Net Income growth
over the last 5 years for Beigene Ltd?

What is the current Free Cash Flow
of Beigene Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Beigene Ltd.

Financials

Balance Sheet Decomposition
Beigene Ltd

Current Assets 29.6B
Cash & Short-Term Investments 22.3B
Receivables 2.5B
Other Current Assets 4.7B
Non-Current Assets 10.6B
Long-Term Investments 643.3m
PP&E 8.5B
Intangibles 967.8m
Other Non-Current Assets 515.4m
Current Liabilities 9.5B
Accounts Payable 3.3B
Accrued Liabilities 1.2B
Short-Term Debt 2.2B
Other Current Liabilities 2.7B
Non-Current Liabilities 3.4B
Long-Term Debt 1.7B
Other Non-Current Liabilities 1.7B
Efficiency

Earnings Waterfall
Beigene Ltd

Revenue
15.6B CNY
Cost of Revenue
-2.4B CNY
Gross Profit
13.1B CNY
Operating Expenses
-22.3B CNY
Operating Income
-9.2B CNY
Other Expenses
2.1B CNY
Net Income
-7.1B CNY

Free Cash Flow Analysis
Beigene Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Beigene Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative Operating Income
28/100
Profitability
Score

Beigene Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Beigene Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
81/100
Solvency
Score

Beigene Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Beigene Ltd

Wall Street analysts forecast Beigene Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beigene Ltd is 138.17 HKD with a low forecast of 122.06 HKD and a high forecast of 163.12 HKD.

Lowest
Price Target
122.06 HKD
36% Upside
Average
Price Target
138.17 HKD
54% Upside
Highest
Price Target
163.12 HKD
82% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Beigene Ltd

1M 1M
-2%
6M 6M
-12%
1Y 1Y
-40%
3Y 3Y
-52%
5Y 5Y
+23%
10Y 10Y
-16%
Annual Price Range
89.85
52w Low
77
52w High
159.6
Price Metrics
Average Annual Return 20.06%
Standard Deviation of Annual Returns 30.52%
Max Drawdown -73%
Shares Statistics
Market Capitalization 123.6B HKD
Shares Outstanding 1 362 652 101
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

News

Other Videos

Company Profile

Beigene Ltd Logo
Beigene Ltd

Country

China

Industry

Biotechnology

Market Cap

123.6B HKD

Dividend Yield

0%

Description

Beigene Ltd is a biotechnology company in the commercial stage. The Company focuses on research and development (R&D), production and commercialization of innovative drugs. The Company has three products approved for listing, including Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317) and Pamiparib (BGB-290). The Company also has eight products in clinical stage, including BGB-283, BGB-A333, BGB-A425, BGB-A1217, BGB-A445, BGB-11417, BGB-10188 and BGB-15025. The Company's business covers China, the United States, Australia, Canada, Singapore, Russia, Brazil, Europe and other countries and regions.

Contact

BEIJING
George Town
C/ O M O U R A N T G O V E R N A N C E S E R V I C E S (C A Y M A N), 94 S O L A R I S A V E N U E, C A M A N A B A Y
+13459494123.0
http://www.beigene.com/

IPO

2016-02-03

Employees

5 151

Officers

Co-Founder, Executive Chairman & CEO
Mr. John V. Oyler
President & COO
Dr. Xiaobin Wu Ph.D.
Co- Chairman of Scientific Advisory Board & Non-Executive Director Co-Founder
Dr. Xiaodong Wang Ph.D.
Global Head of R&D
Mr. Wang Lai Ph.D.

See Also

Discover More
What is the Intrinsic Value of one Beigene Ltd stock?

The intrinsic value of one Beigene Ltd stock under the Base Case scenario is 126.33 HKD.

Is Beigene Ltd stock undervalued or overvalued?

Compared to the current market price of 89.85 HKD, Beigene Ltd is Undervalued by 29%.